Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Schneider

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Cancer Research|May 31, 2014
miR-155 drives telomere fragility in human breast cancer by targeting TRF1Roberto Dinami, Cristiana Ercolani, Eleonora Petti, et al.
British Journal of Clinical Pharmacology|July 15, 2018
Development of a standardized chart review method to identify drug-related hospital admissions in older peopleStefanie Thevelin, Anne Spinewine, Jean-Baptiste Beuscart, et al.
Disease Markers|December 21, 2020
A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow ValidationCatia Mio, Adriana Cifù, Stefania Marzinotto, et al.
Plos One|December 14, 2012
GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migrationMassimilano Scolz, Per O Widlund, Silvano Piazza, et al.
BMJ (Clinical Research Ed.)|May 24, 2023
Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trialKatharina Tabea Jungo, Anna-Katharina Ansorg, Carmen Floriani, et al.
JAMA Network Open|July 27, 2022
Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With MultimorbidityClaudio Schneider, Carole E Aubert, Cinzia Del Giovane, et al.
Circulation Research|April 25, 2009
Multipotent progenitor cells are present in human peripheral bloodDaniela Cesselli, Antonio Paolo Beltrami, Silvia Rigo, et al.
Cancer Cell|July 12, 2011
A Pin1/mutant p53 axis promotes aggressiveness in breast cancerJavier E Girardini, Marco Napoli, Silvano Piazza, et al.
Stem Cells (Dayton, Ohio)|July 30, 2014
Specific mesothelial signature marks the heterogeneity of mesenchymal stem cells from high-grade serous ovarian cancerRoberto Verardo, Silvano Piazza, Enio Klaric, et al.
Plos One|May 1, 2018
Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?Claudio Schneider, Martin Feller, Douglas C Bauer, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Cancer Research|May 31, 2014
miR-155 drives telomere fragility in human breast cancer by targeting TRF1Roberto Dinami, Cristiana Ercolani, Eleonora Petti, et al.
British Journal of Clinical Pharmacology|July 15, 2018
Development of a standardized chart review method to identify drug-related hospital admissions in older peopleStefanie Thevelin, Anne Spinewine, Jean-Baptiste Beuscart, et al.
Disease Markers|December 21, 2020
A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow ValidationCatia Mio, Adriana Cifù, Stefania Marzinotto, et al.
Plos One|December 14, 2012
GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migrationMassimilano Scolz, Per O Widlund, Silvano Piazza, et al.
BMJ (Clinical Research Ed.)|May 24, 2023
Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trialKatharina Tabea Jungo, Anna-Katharina Ansorg, Carmen Floriani, et al.
JAMA Network Open|July 27, 2022
Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With MultimorbidityClaudio Schneider, Carole E Aubert, Cinzia Del Giovane, et al.
Circulation Research|April 25, 2009
Multipotent progenitor cells are present in human peripheral bloodDaniela Cesselli, Antonio Paolo Beltrami, Silvia Rigo, et al.
Cancer Cell|July 12, 2011
A Pin1/mutant p53 axis promotes aggressiveness in breast cancerJavier E Girardini, Marco Napoli, Silvano Piazza, et al.
Stem Cells (Dayton, Ohio)|July 30, 2014
Specific mesothelial signature marks the heterogeneity of mesenchymal stem cells from high-grade serous ovarian cancerRoberto Verardo, Silvano Piazza, Enio Klaric, et al.
Plos One|May 1, 2018
Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?Claudio Schneider, Martin Feller, Douglas C Bauer, et al.
Pageof 8